The Roper Global Diabetes Program provides the definitive global perspective on diabetes. Supported by the major players in the diabetes market, the Roper Diabetes Patient Market Studies – considered the gold standard of diabetes research – provide a unique source of comparable patient information worldwide, along with extensive trending.
Based on feedback from diagnosed patients, the studies give key information on every facet of diabetes from patient attitudes and demographics, to product awareness and usage, to source of care and insurance/reimbursement.
Key studies include:
Since 1989, The Roper U.S. Diabetes Patient Market Study has set the gold standard for understanding diabetes patients' attitudes and behavior. The study provides trended insights into all the major therapeutic segments important to your business as well as a unique array of critical intelligence to help you assess changes in therapy and monitoring practices, patient perceptions, demographics and product and brand usage. Study highlights include:
The Roper U.S. Latino Diabetes Patient Market Study provides deep insight into the Latino diabetes market – one of the fastest-growing segments of the U.S. diabetes population. The study delivers critical information on:
Patient Market Studies in Western and Eastern Europe,
Canada, Asia Pacific and Latin America:
These geographically concentrated studies provide detailed overviews of diagnosed diabetes patients in Western Europe (France, Germany, Italy, the Netherlands, Spain, United Kingdom), Eastern Europe (Poland, Russia, Turkey), Canada, Asia Pacific (China, India, Japan) and Latin America (Argentina, Brazil, Mexico). The studies include:
This study monitors changes in the health status and treatment of pre-diabetics in the U.S., United Kingdom, France and Germany. By examining pre-diabetic patients’ media habits and demographics, as well as attitudes toward their health and care, the study tracks how this condition progresses and provides powerful insights that help you:
Study sponsors benefit from unparalleled strategic information that enables them to know their patient, understand their competitive position and identify unmet needs for their products.
In addition to ensuring that particular studies are conducted for a given year, sponsors also benefit from a cost-sharing approach, have the opportunity to influence study questionnaires and ask their own proprietary questions. All study sponsors receive a combination of the following deliverables:

David Jacobson
Sr. Vice President, Roper Diabetes Program
212.240.5325
djacobson@gfkmm.com